MRPL23 and gastric cancer: It has been reported that MRPL23 can suppress the proliferation of gastric cancer cells and enhance the therapeutic efficacy of adenoviral-mediated p53 gene transfer in models of human gastric cancer by inhibiting MDM2-mediated p53 degradation [33–35].